Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction

  • Markus Moehler1Email author,
  • Ines Gockel1Email author,
  • Hans-Peter Roessler1,
  • Dirk Arnold2,
  • Tanja Trarbach3,
  • Thomas Thomaidis1,
  • Gunther Klautke4,
  • Claus Rödel5,
  • Baruch Brenner6,
  • Hauke Lang1,
  • Peter R Galle1,
  • Carl C Schimanski1 and
  • Heinz Schmidberger1
BMC Cancer201313:75

DOI: 10.1186/1471-2407-13-75

Received: 19 May 2012

Accepted: 4 February 2013

Published: 11 February 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
19 May 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
6 Sep 2012 Reviewed Reviewer Report - Donald Richards
17 Sep 2012 Reviewed Reviewer Report - Thomas Ruhstaller
Resubmission - Version 3
Submitted Manuscript version 3
10 Nov 2012 Author responded Author comments - Markus Moehler
Resubmission - Version 4
10 Nov 2012 Submitted Manuscript version 4
20 Nov 2012 Reviewed Reviewer Report - Thomas Ruhstaller
27 Nov 2012 Reviewed Reviewer Report - Donald Richards
18 Jan 2013 Author responded Author comments - Markus Moehler
Resubmission - Version 5
18 Jan 2013 Submitted Manuscript version 5
24 Jan 2013 Author responded Author comments - Markus Moehler
Resubmission - Version 6
24 Jan 2013 Submitted Manuscript version 6
30 Jan 2013 Author responded Author comments - Markus Moehler
Resubmission - Version 7
30 Jan 2013 Submitted Manuscript version 7
Publishing
4 Feb 2013 Editorially accepted
11 Feb 2013 Article published 10.1186/1471-2407-13-75

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
I. Medical Department, Johannes-Gutenberg University Mainz
(2)
IV. Medical Department, University Halle-Wittenberg
(3)
West German Cancer Centre, University Hospital
(4)
Radiotherapy Department, University Rostock
(5)
Radiotherapy Department, Johann-Wolfgang-Goethe University
(6)
Institute of Oncology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petach-Tiqva, and Sackler Faculty of Medicine, Tel-Aviv University

Advertisement